1.
Interstitial nephritis secondary to treatment with pembrolizumab, a rare complication in two patients with lung adenocarcinoma. Monaldi Arch Chest Dis [Internet]. 2022 Jul. 28 [cited 2025 Jun. 14];93(2). Available from: https://www.monaldi-archives.org/macd/article/view/2368